Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-21-000004

Options or other derivatives

  • Chief Financial Officer acquired 55,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Biller Jonathan · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-10 Grant or award : show line 1 in the form Restricted stock units +11,000 11,000 D
2021-02-10 Grant or award : show line 2 in the form Stock option (right to buy) +44,000 44,000 D
Loading xslF345X03/wf-form4_161316492476489.xml…